|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.11 USD | -1.14% |
|
+14.57% | +39.84% |
| 05-24 | JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating | MT |
| 05-24 | Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating | MT |
Cellebrite DI Ltd. announced that Dr. Guy Rotkopf, former Director General of the Israel Ministry of Justice, has been named as the new Chairperson of Cellebrite's Ethics & Integrity Committee. Dr. Rotkopf brings to the Committee a strong law and academic background. Dr. Rotkopf has a PH.
D. in law from Bar-Ilan University, an LL. M from Duke University School of Law, and an LL. B in law from the Academic College of Management.
| 1st Jan change | Capi. | |
|---|---|---|
| +39.84% | 2.49B | |
| +14.62% | 90.43B | |
| +14.59% | 85.57B | |
| +37.27% | 52.49B | |
| -19.27% | 50.25B | |
| +32.93% | 46.79B | |
| +83.75% | 42.74B | |
| -32.70% | 41.67B | |
| -1.24% | 27.82B | |
| -23.23% | 22.46B |
CELLEBRITE DI LTD. 
